Troponin dependent 30-day mortality in patients with acute pulmonary embolism
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Troponin dependent 30-day mortality in patients with acute pulmonary embolism. / Sonne-Holm, Emilie; Winther-Jensen, Matilde; Bang, Lia E.; Køber, Lars; Fosbøl, Emil; Carlsen, Jørn; Kjaergaard, Jesper.
I: Journal of Thrombosis and Thrombolysis, Bind 56, Nr. 3, 2023, s. 485-494.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Troponin dependent 30-day mortality in patients with acute pulmonary embolism
AU - Sonne-Holm, Emilie
AU - Winther-Jensen, Matilde
AU - Bang, Lia E.
AU - Køber, Lars
AU - Fosbøl, Emil
AU - Carlsen, Jørn
AU - Kjaergaard, Jesper
N1 - Publisher Copyright: © 2023, The Author(s).
PY - 2023
Y1 - 2023
N2 - Background: Troponin concentrations above upper reference are associated with increased mortality in patients with pulmonary embolism (PE). We aimed to assess whether risk of 30-day mortality increases in a dose-response relationship with concentration of troponin. Methods: Using Danish national registries, we identified patients ≥ 18 years of age hospitalized with first-time PE between 2013 and 2018 and available troponin measurements − 1/+1 day from admission. Patients were stratified into quintiles by increasing troponin concentration. Risk of 30-day mortality was assessed performing cumulative mortality curves and Cox regression model comparing the troponin quintiles. Results: We identified 5,639 PE patients of which 3,278 (58%) had a troponin concentration above upper reference. These patients were older (74 years), 50% male and with heavier comorbidity compared to patients with non-elevated troponin. We found increasing 30-day mortality with increasing troponin concentration (1% in 1st quintile (95% CI 0.5–1.5%), 2% in 2nd quintile (95% CI 1-2.5%), 8% in 3rd quintile (95% CI 5–9%), 11% in 4th quintile (95% CI 9–13%) and 15% in 5th quintile (95% CI 13–16%), confirmed in a Cox model comparing 1st quintile with 2nd quintile (HR 1.09; 95% CI 0.58–2.02), 3rd quintile (HR 3.68; 95% CI 2.20–6.15), 4th quintile (HR 5.51; 95% CI 3.34–9.10) and 5th quintile (HR 8.09; 95% CI 4.95–13.23). Conclusion: 30-day mortality was strongly associated with troponin concentration useful for improving risk stratification, treatment strategies and outcomes in PE patients.
AB - Background: Troponin concentrations above upper reference are associated with increased mortality in patients with pulmonary embolism (PE). We aimed to assess whether risk of 30-day mortality increases in a dose-response relationship with concentration of troponin. Methods: Using Danish national registries, we identified patients ≥ 18 years of age hospitalized with first-time PE between 2013 and 2018 and available troponin measurements − 1/+1 day from admission. Patients were stratified into quintiles by increasing troponin concentration. Risk of 30-day mortality was assessed performing cumulative mortality curves and Cox regression model comparing the troponin quintiles. Results: We identified 5,639 PE patients of which 3,278 (58%) had a troponin concentration above upper reference. These patients were older (74 years), 50% male and with heavier comorbidity compared to patients with non-elevated troponin. We found increasing 30-day mortality with increasing troponin concentration (1% in 1st quintile (95% CI 0.5–1.5%), 2% in 2nd quintile (95% CI 1-2.5%), 8% in 3rd quintile (95% CI 5–9%), 11% in 4th quintile (95% CI 9–13%) and 15% in 5th quintile (95% CI 13–16%), confirmed in a Cox model comparing 1st quintile with 2nd quintile (HR 1.09; 95% CI 0.58–2.02), 3rd quintile (HR 3.68; 95% CI 2.20–6.15), 4th quintile (HR 5.51; 95% CI 3.34–9.10) and 5th quintile (HR 8.09; 95% CI 4.95–13.23). Conclusion: 30-day mortality was strongly associated with troponin concentration useful for improving risk stratification, treatment strategies and outcomes in PE patients.
KW - Epidemiology
KW - Mortality
KW - Pulmonary embolism
KW - Risk assessment
KW - Troponin
U2 - 10.1007/s11239-023-02864-0
DO - 10.1007/s11239-023-02864-0
M3 - Journal article
C2 - 37486553
AN - SCOPUS:85165591921
VL - 56
SP - 485
EP - 494
JO - Journal of Thrombosis and Thrombolysis
JF - Journal of Thrombosis and Thrombolysis
SN - 0929-5305
IS - 3
ER -
ID: 365709705